AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18177949
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D intervention, specific dosage and duration not available
Trial: 9917782
Drug: Topical anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthesia plus intracameral 1% preservative-free lidocaine
Trial: 9917782
Drug: Intracameral balanced
RxNorm normalized name: bimatoprost
DrugBank: Bimatoprost (DB00905)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intracameral balanced salt solution
Trial: 2182208
Drug: Lidocaine treatment
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine treatment (100 mg bolus followed by 2 mg.kg-1 for at least the first 24 hours)
Trial: 22084333
Drug: 90-Hz WBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90-Hz WBV therapy
Trial: 22084333
Drug: 30-Hz WBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30-Hz WBV therapy
Trial: 22084333
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no WBV therapy)
Trial: 17016233
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy and radiotherapy
Trial: 15799931
Drug: Cypher drug-eluting
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cypher drug-eluting stents
Trial: 8397489
Drug: Granisetron 2
RxNorm normalized name: granisetron 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 2 mg once daily, administered either as a single dose or repeated for 2 to 6 days.
Trial: 6973989
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg fluproquazone
Trial: 6996931
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg paracetamol
Trial: 29492612
Drug: Oral TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral TXA (two doses of 20 mg/kg)
Trial: 29492612
Drug: Intravenous TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous TXA (two doses of 15 mg/kg)
Trial: 20733096
Drug: Atrasentan (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrasentan (10 mg)
Trial: 11979505
Drug: calcium (500
RxNorm normalized name: calcium gluconate 45 mg calcium (500 mg) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: calcium (500 mg day(‐1)) + calcitonin (nasal spray 100 U day(‐1))
Trial: 10811549
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate 100 mg
Trial: 7149969
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate 250 mg
Trial: 21703724
Drug: Whole Body
RxNorm normalized name: MaxiVision Whole Body Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole Body Vibration (WBV) at a frequency of 6 Hz for 5 consecutive days, daily series of 5 periods of 1 minute
Trial: 12118758
Drug: Standard postoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard postoperative respiratory therapy
Trial: 28755409
Drug: REGN1193 (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: REGN1193 (0.05 to 0.6 mg/kg)
Trial: 28755409
Drug: REGN1193 (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: REGN1193 (0.6 mg/kg)
Trial: 28755409
Drug: REGN1193 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: REGN1193 (all doses)
Trial: 22850268
Drug: Sertindole (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertindole (mean dose=17 mg/day)
Trial: 22850268
Drug: Olanzapine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (mean dose=16 mg/day)
Trial: 15223075
Drug: High-flavanol cocoa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flavanol cocoa drink (HFCD; 187 mg flavan-3-ols/100 ml)
Trial: 15223075
Drug: Low-flavanol cocoa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-flavanol cocoa drink (LFCD; 14 mg/100 ml)
Trial: 9285502
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of alpha-lipoic acid (ALA) 1,200 mg
Trial: 9285502
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of alpha-lipoic acid (ALA) 600 mg
Trial: 9285502
Drug: Hamburg Pain
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hamburg Pain Adjective List (HPAL) total scale with ALA 1,200 mg
Trial: 9285502
Drug: Hamburg Pain
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hamburg Pain Adjective List (HPAL) total scale with ALA 600 mg
Trial: 9285502
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral dose of alpha-lipoic acid (ALA) 800 mg
Trial: 23347721
Drug: Nebulized naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized naloxone (2 mg in 3 mL normal saline)
Trial: 15671203
Drug: CHF3381 (100,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHF3381 (100, 200, and 400 mg twice daily for 2 weeks)
Trial: 2956296
Drug: Isotretinoin (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotretinoin (various dosage schedules)
Trial: 23706887
Drug: Building Our
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Building Our Solutions and Connections (BOSC) intervention
Trial: 16818832
Drug: Peer counselor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peer counselor intervention (weekly for 6 weeks)
Trial: 11081343
Drug: Hemodialysis therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hemodialysis therapy
Trial: 1844997
Drug: All beverages
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All beverages (heart rate, rectal temperature, perceived exertion)
Trial: 30632329
Drug: 0.2% bio-adhesive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% bio-adhesive chlorhexidine gel
Trial: 26849799
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E supplementation at 400 mg per day
Trial: 18567081
Drug: 5-aminosalicylic acid
RxNorm normalized name: 5-aminosalicylic acid
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-aminosalicylic acid (5-ASA) suppository
Trial: 15778427
Drug: lopinavir/ritonavir (800/200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lopinavir/ritonavir (800/200 mg qd or 400/100 mg bid)
Trial: 12028208
Drug: Sequential treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential treatment with calcium alginate dressings (UrgoSorb) for 4 weeks followed by hydrocolloid dressings (Algoplaque) for 4 weeks
Trial: 10375362
Drug: Iron fortified
RxNorm normalized name: INFANT FORMULA SMA IRON FORTIFIED PWD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron fortified preterm formula (0.9 mg/dl iron)
Trial: 10375362
Drug: Fortified term
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fortified term formula (0.5 mg/dl iron)
Trial: 10375362
Drug: Preterm formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preterm formula (0.9 mg/dl iron) followed by term formula (0.5 mg/dl iron)
Trial: 2216187
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g cefazolin administered intramuscularly
Trial: 2216187
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g cefazolin administered intravenously
Trial: 319541
Drug: Metoprolol 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 120 mg/d
Trial: 319541
Drug: Metoprolol 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 120 mg/d and 210 mg/d pooled results
Trial: 7934973
Drug: Propranolol 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 240 mg/d
Trial: 319541
Drug: Propranolol 360
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 360 mg/d
Trial: 24660151
Drug: Oral dextrose
RxNorm normalized name: Dextrose
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dextrose 10% given at 3 and 6 hours prior to the operation
Trial: 24343071
Drug: Premedication with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Premedication with 40 mg parecoxib sodium and infiltration of 0.5% ropivacaine (20 mL)
Trial: 24343071
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (2 mL) intravenously before anesthesia induction and infiltration of 0.5% ropivacaine (20 mL)
Trial: 12139206
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride (20 mg twice daily)
Trial: 1463527
Drug: Loracarbef (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loracarbef (400 mg b.i.d.)
Trial: 1463527
Drug: Amoxicillin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (500 mg t.i.d.)
Trial: 6509782
Drug: Dopamine receptor
RxNorm normalized name: Dopamine receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine receptor blockade (domperidone 10 mg i.v.) in acromegalic subjects
Trial: 6509782
Drug: Dopamine receptor
RxNorm normalized name: Dopamine receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine receptor blockade (domperidone 10 mg i.v.) in normal controls
Trial: 6509782
Drug: Intramuscular growth
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular growth hormone (three injections of 4 IU) before domperidone
Trial: 30083962
Drug: tivantinib 360
RxNorm normalized name: Tivantinib
DrugBank: Tivantinib (DB12200)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tivantinib 360 mg PO BID
Trial: 27234001
Drug: Can Do
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Can Do Treatment (CDT)
Trial: 7621454
Drug: External radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External radiation therapy
Trial: 28199397
Drug: Topical dorzolamide/timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical dorzolamide/timolol
Trial: 28199397
Drug: Oral acetazolamide
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral acetazolamide and topical dexamethasone
Trial: 24456143
Drug: Post-fatigue laser
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-fatigue laser treatment
Trial: 24456143
Drug: Pre-fatigue laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-fatigue laser treatment
Trial: 21134997
Drug: Varenicline 1
RxNorm normalized name: varenicline 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline 1 mg twice daily for 12 weeks
Trial: 6893692
Drug: Molsidomine (M)
RxNorm normalized name: molsidomine
DrugBank: Molsidomine (DB09282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine (M) 4 mg, single dose
Trial: 6893692
Drug: Molsidomine (M),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine (M), prolonged treatment
Trial: 6893692
Drug: Molsidomine (M),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine (M), single dose
Trial: 30921748
Drug: Brief cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief cognitive therapies
Trial: 26844926
Drug: Inhaled allergen
RxNorm normalized name: Inhaled allergen mix specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled allergen
Trial: 27886976
Drug: Inhaled diesel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled diesel exhaust (DE) and allergen co-exposure
Trial: 14981009
Drug: GLP-1 infusion
RxNorm normalized name: Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 infusion (1.5 pmol/kg per minute) for 72 hours
Trial: 11316375
Drug: Naltrexone 50
RxNorm normalized name: naltrexone 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 50 mg + Relapse Prevention Therapy (RP)
Trial: 11316375
Drug: Naltrexone 0
RxNorm normalized name: MORPHINE 20MG/NALTREXONE 0.8MG SA CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 0 mg + Relapse Prevention Therapy (RP)
Trial: 11316375
Drug: Naltrexone 50
RxNorm normalized name: naltrexone 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 50 mg + Drug Counseling
Trial: 11316375
Drug: Naltrexone 0
RxNorm normalized name: MORPHINE 20MG/NALTREXONE 0.8MG SA CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 0 mg + Drug Counseling
Trial: 10638409
Drug: 2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/kg MDE
Trial: 2658525
Drug: Penbutolol 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penbutolol 10 mg/day
Trial: 2658525
Drug: Penbutolol 20
RxNorm normalized name: penbutolol 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penbutolol 20 mg/day
Trial: 2658525
Drug: Penbutolol 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penbutolol 40 mg/day
Trial: 901695
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg metoprolol tartrate
Trial: 901695
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg metoprolol tartrate
Trial: 31025258
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of rocuronium 0.6 mg·kg−1·hr−1
Trial: 29178954
Drug: Colloidal silver
RxNorm normalized name: COLLOIDAL SILVER
DrugBank: Silver (DB12965)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloidal silver (CS) nasal spray, administered twice daily for six weeks
Trial: 29178954
Drug: Saline nasal
RxNorm normalized name: Ayr Saline Nasal
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline nasal spray, administered twice daily for six weeks
Trial: 25467016
Drug: Lapatinib (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib (1000 mg orally daily)
Trial: 25467016
Drug: Trastuzumab (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trastuzumab (4 mg/kg loading dose followed by 2 mg/kg weekly)
Trial: 25467016
Drug: Trastuzumab +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trastuzumab + Lapatinib (at the same doses)
Trial: 21153021
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (ZOL) 5 mg infused once yearly
Trial: 18294736
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIg) added to approved AD therapies for 6 months, then discontinued, and resumed for another 9 months
Trial: 18028126
Drug: Topical recombinant
RxNorm normalized name: thrombin topical recombinant 5000 intl units topical powder for reconstitution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical recombinant human acidic fibroblast growth factor (rh‐aFGF)
Trial: 11772241
Drug: Aminolevulinic acid
RxNorm normalized name: Aminolevulinic Acid
DrugBank: Aminolevulinic acid (DB00855)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aminolevulinic acid (ALA) in photodynamic therapy (PDT)
Trial: 11772241
Drug: ALA treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALA treatment for non-tumoural applications
Trial: 7909853
Drug: Salmeterol xinafoate
RxNorm normalized name: Salmeterol Xinafoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol xinafoate (42 micrograms inhaled twice daily)
Trial: 7909853
Drug: Albuterol (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (180 micrograms inhaled four times daily)
Trial: 30098961
Drug: 400/200 eicosapentaenoic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400/200 eicosapentaenoic acid (EPA)/docosahexaenoic acid (DHA) fish oil at 2 g
Trial: 30098961
Drug: Almost pure
RxNorm normalized name: Dream Pure BB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almost pure EPA at 2 g
Trial: 26556736
Drug: MK-5442 (5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-5442 (5, 7.5, 10, or 15 mg daily)
Trial: 26556736
Drug: MK-5442 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-5442 (10 mg)
Trial: 26556736
Drug: ALN 70
RxNorm normalized name: ALN-AT3SC
DrugBank: Fitusiran (DB15002)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALN 70 mg weekly
Trial: 25662545
Drug: Glucosamine (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucosamine (1500 mg) and Chondroitin (1200 mg) combination
Trial: 25662545
Drug: Tramadol HCl
RxNorm normalized name: tramadol HCl
DrugBank: Tramadol (DB00193)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tramadol HCl (50 mg, twice daily)
Trial: 20669577
Drug: Needle warming
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle warming therapy
Trial: 31567988
Drug: Electroacupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture treatment
Trial: 20669577
Drug: Body acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Body acupuncture treatment
Trial: 14616152
Drug: Rabeprazole (RB)
DrugBank: Rabeprazole (DB01129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rabeprazole (RB) 20 mg/d in the evening (p.m.)
Trial: 14616152
Drug: Rabeprazole (RB)
DrugBank: Rabeprazole (DB01129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rabeprazole (RB) 20 mg/d in the morning (a.m.)
Trial: 11062356
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus 500 mg calcium supplement
Trial: 8629588
Drug: Digoxin (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin (0.25 mg/day orally)
Trial: 10910491
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg meperidine
Trial: 1599888
Drug: 12.5 mg
RxNorm normalized name: rutin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg bupivacaine
Trial: 1599888
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg meperidine plus 12.5 mg bupivacaine
Trial: 1599888
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg bupivacaine
Trial: 1599888
Drug: 37.5 mg
RxNorm normalized name: pemoline 37.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 37.5 mg bupivacaine
Trial: 29792370
Drug: belimumab 10
RxNorm normalized name: Belimumab
DrugBank: Belimumab (DB08879)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: belimumab 10 mg/kg plus standard of care (SoC)
Trial: 22440488
Drug: Ibuprofen 600
RxNorm normalized name: ibuprofen 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 600 mg, 3 times daily, starting 6 hours before ascent
Trial: 19341510
Drug: Sertraline (flexible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (flexible dosages up to 200 mg/d)
Trial: 19341510
Drug: Cognitive-behavioural group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural group therapy (one individual session and nine group sessions per 90 min)
Trial: 19341510
Drug: Patients' choice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients' choice arm (sertraline or cognitive-behavioural group therapy)
Trial: 17493418
Drug: Rosuvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (10 mg/d)
Trial: 11154053
Drug: Sheng-ji-san (SJS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sheng-ji-san (SJS) treatment combined with routine medical care
Trial: 6149535
Drug: Almitrine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almitrine (1.5 mg/kg orally)
Trial: 30095981
Drug: Bimagrumab 30
RxNorm normalized name: Bimagrumab
DrugBank: Bimagrumab (DB12584)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimagrumab 30 mg/kg intravenously
Trial: 26978497
Drug: Nonspecific cytoprotective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonspecific cytoprotective therapy (cytoflavin)
Trial: 15169706
Drug: Risperidone treatment
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Risperidone treatment for 6 months
Trial: 21782166
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) 100 mg/day for 5 days
Trial: 21782166
Drug: Raloxifene (R)
DrugBank: Raloxifene (DB00481)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Raloxifene (R) 100 mg/day for 5 days
Trial: 17570206
Drug: Combination antibiotic
RxNorm normalized name: combinations of different antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination antibiotic therapy (clarithromycin 750 mg/day, rifabutin 450 mg/day, clofazimine 50 mg/day)
Trial: 9356530
Drug: Combined dose
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined dose of beta-carotene and canthaxanthin